Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603858'
s Pretax Margin % Range Over the Past 10 Years
Min: -8.42 Med: 12.11 Max: 17.08
Current: 4.63
SHSE:603858's Pretax Margin % is ranked worse than 55.57% of 961
companies
in the Drug Manufacturers industry
Industry Median: 7.06
vs SHSE:603858: 4.63
Shandong Buchang Pharmaceuticals Co (SHSE:603858) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Shandong Buchang Pharmaceuticals Co Pretax Margin % Related Terms
Shandong Buchang Pharmaceuticals Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Buchang Pharmaceuticals Co Pretax Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Buchang Pharmaceuticals Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Buchang Pharmaceuticals Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shandong Buchang Pharmaceuticals Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Buchang Pharmaceuticals Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Buchang Pharmaceuticals Co (SHSE:603858) has a Pretax Margin % of 14.83% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Shandong Buchang Pharmaceuticals Co and its competitors. This is 22% above median its historical median of 12.11. According to the industry distribution chart, Shandong Buchang Pharmaceuticals Co ranks #534 out of 961 companies in the Drug Manufacturers industry, placing it in the top 55.6%.
Is Shandong Buchang Pharmaceuticals Co's Pretax Margin % too high?
Shandong Buchang Pharmaceuticals Co's current Pretax Margin % of 14.83% is 22% above median its 10-year median of 12.11. The Drug Manufacturers industry median Pretax Margin % is 7.06. Shandong Buchang Pharmaceuticals Co's value of 14.83% is 110.1% above this industry median. Based on the distribution chart, Shandong Buchang Pharmaceuticals Co ranks #534 out of 961 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Shandong Buchang Pharmaceuticals Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shandong Buchang Pharmaceuticals Co's Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shandong Buchang Pharmaceuticals Co ranks #534 out of 961 companies for Pretax Margin %. This places Shandong Buchang Pharmaceuticals Co in the lower half of its industry. The industry median Pretax Margin % is 7.06. Shandong Buchang Pharmaceuticals Co's value of 14.83% is 110.1% above this benchmark. While the company's 10-year median is 12.11 vs. the industry median of 7.06, Shandong Buchang Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.06, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Buchang Pharmaceuticals Co's current Pretax Margin % of 14.83% is 110.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Shandong Buchang Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Buchang Pharmaceuticals Co's current Pretax Margin % is 14.83%, which is 22% above median its own 10-year median of 12.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Buchang Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co (SHSE:603858) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.94, compared to a current price of ¥15.66 — trading 1.8% below its estimated fair value. The current Pretax Margin % is 14.83%, which is 22% above median its 10-year median of 12.11 and 110.1% above the Drug Manufacturers industry median of 7.06. Shandong Buchang Pharmaceuticals Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Shandong Buchang Pharmaceuticals Co (SHSE:603858), the current Pretax Margin % is 14.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Buchang Pharmaceuticals Co (SHSE:603858) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co stock appears to be undervalued.
The current stock price of ¥15.66 is trading 1.8% below its estimated GF Value™ of ¥15.94.
GuruFocus considers Shandong Buchang Pharmaceuticals Co to be Fairly Valued.
Key valuation signals for SHSE:603858:
Pretax Margin %: 14.83% (22% above median its 10-year median of 12.11)
GF Value™: ¥15.94 vs. price of ¥15.66 (1.8% below fair value)
Industry Position: 110.1% above the Drug Manufacturers median (#534 of 961)
No single metric tells the full story. See the SHSE:603858 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603858 has been successfully added to your 
